Jeffrey L. Rutherford - 13 May 2022 Form 4 Insider Report for DIEBOLD NIXDORF, Inc (DBD)

Role: EVP and CFO
Signature: Jonathan B. Leiken, Attorney-in-fact for Jeffrey L. Rutherford
Issuer symbol: DBD
Transactions as of: 13 May 2022
Net transactions value: +$50,295
Form type: 4
Filing time: 13 May 2022, 12:25:26 UTC
Previous filing: 12 May 2022
Next filing: 01 Feb 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	DBD	Common Shares	Purchase	$50,295	+14,784	+3.4%	$3.40	447,340	13 May 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	DBD	Non-Qualified Stock Option						68,572	13 May 2022	Common Shares	68,572	$4.08	Direct	F2
holding	DBD	Non-Qualified Stock Option						18,898	13 May 2022	Common Shares	18,898	$11.96	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Number includes restricted stock units.
F2	Granted under the 2017 Equity and Performance Incentive Plan; option is generally exercisable in annual increments of 1/3, 1/3, 1/3 beginning one year from the date of grant.